Ep. 585 CPT Code Updates for the OBL with Dr. Goke Akinwande

Ep. 585 CPT Code Updates for the OBL with Dr. Goke Akinwande

With the annual trend of fluctuating reimbursement rates, have you been on the fence about turning your OBL into an ASC? Make sure your OBL is prepared for the surprising changes in coding coming in 2026. In this episode, Dr. Mary Costantino partners with fellow OBL owner Dr. Goke Akinwande and revenue cycle management expert Laurie Bouzarelos to review the new CPT code changes and how they translate to OBL and ASC reimbursement.---SYNPOSISDr. Akinwande discusses many positive takeaways after diving into the recent Medicare documents, and highlights key shifts. He believes these changes to add-on codes and territories means one thing: CLI is being heard. The upcoming code changes improve delineation of vascular territories, differentiating between "simple" (stenosis) and "complex" (CTO) procedures. These changes are aimed at rewarding physicians performing the difficult CLI work while decreasing reimbursement for more straightforward cases.Beyond the CPT code specifics, the conversation also covers real-world implications for OBL owners. Dr. Akinwande explains why these changes might narrow the reimbursement gap between OBLs and ASCs, prompting him to warn against ASC conversion. Laurie Bouzarelos provides guidance on implementation, stressing the importance of updating charge masters, reviewing payer contracts for "gap fill" clauses, and monitoring payments once the new codes go live. The episode ends with a discussion on obstacles in billing, collections, and the need for physicians to master the business side of their practice to ensure financial success.---TIMESTAMPS00:00 - Introduction04:37 - 2026 CPT Changes Overview07:18 - Simple vs. Complex Codes13:16 - Key Add-on Codes19:52 - OBL vs. ASC Conversion?24:56 - IVL Reimbursement Trends29:18 - Update Your Charge Master41:41 - Pricing & Medicare Year46:39 - Billing & Collections Reality

Avsnitt(642)

Ep. 518 Long-Term Outcomes of Prostatic Artery Embolization (PAE) with Dr. Shivank Bhatia

Ep. 518 Long-Term Outcomes of Prostatic Artery Embolization (PAE) with Dr. Shivank Bhatia

Do we finally have definitive data on the efficacy of prostate artery embolization (PAE)? Dr. Shivank Bhatia (interventional radiologist at University of Miami) joins host Dr. Michael Barraza to discu...

18 Feb 202555min

Ep. 517 Complex HCC Patients and the "Grey Zone": What to Do When You Don’t Know What to Do

Ep. 517 Complex HCC Patients and the "Grey Zone": What to Do When You Don’t Know What to Do

Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to palliative intent. To explore the "grey zone" of treatment goals for intermediate-stage ...

14 Feb 202540min

Ep. 516 Dialysis Procedures: New Tools for Better Outcomes with Dr. Ari Kramer and Dr. Omar Davis

Ep. 516 Dialysis Procedures: New Tools for Better Outcomes with Dr. Ari Kramer and Dr. Omar Davis

Given the challenges that our dialysis patients face, how can we as providers stay sharp with the latest access techniques to help ensure the best possible outcomes? Dr. Omar Davis (interventional nep...

11 Feb 20251h 13min

Ep. 515 Curative Intent Therapies for HCC: Today and Tomorrow

Ep. 515 Curative Intent Therapies for HCC: Today and Tomorrow

For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation can be a curative treatment. With multiple ablation options available and still un...

7 Feb 202553min

Ep. 514 Deep Sedation in IR: Intro to Ketamine with Dr. Amy Deipolyi

Ep. 514 Deep Sedation in IR: Intro to Ketamine with Dr. Amy Deipolyi

When deep sedation is required, it can be challenging to implement due to the difficulty of scheduling dedicated anesthesia coverage in the IR suite. Dr. Amy Deipolyi (interventional radiologist and D...

4 Feb 202534min

Ep. 513 Combination Therapy and Clinical trials for Advanced HCC: What They Really Mean

Ep. 513 Combination Therapy and Clinical trials for Advanced HCC: What They Really Mean

In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative to tyrosine kinase inhibitors and chemotherapy, making it an exciting time to be...

31 Jan 202548min

Ep. 512 The "Alzate Maneuver”: Flipping Retrograde Access with Dr. Gregg Alzate

Ep. 512 The "Alzate Maneuver”: Flipping Retrograde Access with Dr. Gregg Alzate

Proximity to innovation often gives rise to further innovation. This trend is especially true in interventional radiology. Dr. Gregg Alzate (interventional radiologist in San Diego, California) joins ...

28 Jan 202550min

Ep. 511 How to Simplify Dosing: Understanding Y-90 Dosimetry from Simple to Complex

Ep. 511 How to Simplify Dosing: Understanding Y-90 Dosimetry from Simple to Complex

Of all the topics covered during interventional radiology training, dosimetry education is often delayed until after IRs enter clinical practice. In this episode, Drs. Tyler Sandow and Sabeen Dhand ho...

24 Jan 202555min

Populärt inom Utbildning

historiepodden-se
rss-bara-en-till-om-missbruk-medberoende-2
det-skaver
alska-oss
harrisons-dramatiska-historia
rss-foraldramotet-bring-lagercrantz
nu-blir-det-historia
roda-vita-rosen
johannes-hansen-podcast
sektledare
rss-viktmedicinpodden
i-vantan-pa-katastrofen
rss-sjalsligt-avkladd
rss-max-tant-med-max-villman
allt-du-velat-veta
sa-in-i-sjalen
not-fanny-anymore
rib-podcast
rss-relationsrevolutionen
rss-traningsklubben